Finally, we dissect chromatin accessibility changes associated with BAP1 and PBRM1 mutations, further illustrating the multi-level interplay between mutational, global, and specific epigenetic alterations, and transcriptomic changes in ccRCC. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.